169 related articles for article (PubMed ID: 16579729)
1. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
3. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activity of parthenolide-depleted Feverfew (Tanacetum parthenium).
Sur R; Martin K; Liebel F; Lyte P; Shapiro S; Southall M
Inflammopharmacology; 2009 Feb; 17(1):42-9. PubMed ID: 19112586
[TBL] [Abstract][Full Text] [Related]
5. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
6. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi: antiprotozoal activity of parthenolide obtained from Tanacetum parthenium (L.) Schultz Bip. (Asteraceae, Compositae) against epimastigote and amastigote forms.
Izumi E; Morello LG; Ueda-Nakamura T; Yamada-Ogatta SF; Filho BP; Cortez DA; Ferreira IC; Morgado-Díaz JA; Nakamura CV
Exp Parasitol; 2008 Mar; 118(3):324-30. PubMed ID: 17950283
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
Groenewegen WA; Heptinstall S
J Pharm Pharmacol; 1990 Aug; 42(8):553-7. PubMed ID: 1981582
[TBL] [Abstract][Full Text] [Related]
10. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro.
Brown AM; Edwards CM; Davey MR; Power JB; Lowe KC
J Pharm Pharmacol; 1997 May; 49(5):558-61. PubMed ID: 9178194
[TBL] [Abstract][Full Text] [Related]
12. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Piela-Smith TH; Liu X
Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats.
Jain NK; Kulkarni SK
J Ethnopharmacol; 1999 Dec; 68(1-3):251-9. PubMed ID: 10624885
[TBL] [Abstract][Full Text] [Related]
14. Patch test reactivity to feverfew-containing creams in feverfew-allergic patients.
Paulsen E; Christensen LP; Fretté XC; Andersen KE
Contact Dermatitis; 2010 Sep; 63(3):146-50. PubMed ID: 20690937
[TBL] [Abstract][Full Text] [Related]
15. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
Mathema VB; Koh YS; Thakuri BC; Sillanpää M
Inflammation; 2012 Apr; 35(2):560-5. PubMed ID: 21603970
[TBL] [Abstract][Full Text] [Related]
16. The Feverfew plant-derived compound, parthenolide enhances platelet production and attenuates platelet activation through NF-κB inhibition.
Sahler J; Bernard JJ; Spinelli SL; Blumberg N; Phipps RP
Thromb Res; 2011 May; 127(5):426-34. PubMed ID: 21272923
[TBL] [Abstract][Full Text] [Related]
17. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
18. Recent advances on the structural modification of parthenolide and its derivatives as anticancer agents.
Liu X; Wang X
Chin J Nat Med; 2022 Nov; 20(11):814-829. PubMed ID: 36427916
[TBL] [Abstract][Full Text] [Related]
19. Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer.
Curry EA; Murry DJ; Yoder C; Fife K; Armstrong V; Nakshatri H; O'Connell M; Sweeney CJ
Invest New Drugs; 2004 Aug; 22(3):299-305. PubMed ID: 15122077
[TBL] [Abstract][Full Text] [Related]
20. Quantification of parthenolide in Tanacetum species by LC-UV/LC-MS and microscopic comparison of Mexican/US feverfew samples.
Avula B; Navarrete A; Joshi VC; Khan IA
Pharmazie; 2006 Jul; 61(7):590-4. PubMed ID: 16889065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
